Coronary artery bypass graft (CABG) and the diabetic patient: current perspectives

References

• American Diabetes Association. Economic Costs of Diabetes in the U.S. 2012. Diabetes Care. 2013:36(4);1033–1046.
   Google Scholar
• Silva JA, Escobar A, Collins TJ, Ramee SR, White CJ. Unstable angina: a comparison of angioscopic findings between diabetic and non-diabetic patients. Circulation. 1995;92(7):1731–1736.
   Web of Science ®Google Scholar
• Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab. 2007;3(1):46–56.
   PubMedGoogle Scholar
• Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation. 2003;108(13):1655–1661.
   PubMed Web of Science ®Google Scholar
• Angioplasty from bench to bedside to bench. King SB. Circulation. 1996;93:1621–1629.
   Web of Science ®Google Scholar
• BARI investigators. Influence of diabetes on 5 year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96(6):1761–1769.
   Web of Science ®Google Scholar
• BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49(15):1600–1606.
   Web of Science ®Google Scholar
• Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94(8):1818–1825.
   Web of Science ®Google Scholar
• Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol. 2000;20(12):2553–2558.
   PubMed Web of Science ®Google Scholar
• Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol. 2000;86(4B):6H–11H.
   Web of Science ®Google Scholar
• Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C. Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res. 2005;97(7):725–733.
   Web of Science ®Google Scholar
• Morss AS, Edelman ER. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem. 2007;282(19):14635–14644.
   PubMed Web of Science ®Google Scholar
• Aronson D. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure. Med Hypotheses. 2002;59(3):297–301.
   PubMed Web of Science ®Google Scholar
• Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(23):e652–e735.
   PubMed Web of Science ®Google Scholar
• Hannan EL, Racz MJ, Gold J, et al; American College of Cardiology; American Heart Association. Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice? Circulation. 2010;121(2):267–275.
   Web of Science ®Google Scholar
• Yates MT, Soppa GKR, Valencia O, Jones S, Firoozi S, Jahangiri M. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease. J Thorac Cardiovasc Surg. Epub February 9, 2013.
   Google Scholar
• Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomized trials. Lancet. 2009;373(9670):1190–1197.
   PubMed Web of Science ®Google Scholar
• Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004;109(19):2273–2278.
   PubMed Web of Science ®Google Scholar
• Hermiller JB, Raizner A, Cannon L, et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005;45(8):1172–1179.
   PubMed Web of Science ®Google Scholar
• Stenestrand U, James SK, Lindbäck J, et al; SCAAR/SWEDEHEART study group. Safety and efficacy of drug-eluting vs bare metal stents in patients with diabetes mellitus: long-term of follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2010;31(2):177–186.
   Web of Science ®Google Scholar
• Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52(14):1134–1140.
   PubMed Web of Science ®Google Scholar
• Lagerqvist B, Carlsson J, Fröbert O, et al; Swedish Coronary Angiography and Angioplasty Registry Study Group. Stent thrombosis in Sweden: a report from the Swedish coronary angiography and angioplasty registry. Circ Cardiovasc Interv. 2009;2(5):401–408.
   PubMed Web of Science ®Google Scholar
• Hoffman DM and Tranbaugh RF. Interventions for coronary artery disease (surgery vs angioplasty) in diabetic patients. Endocrinology and metabolism clinics of North America. 2014;(43)1. In press.
   Web of Science ®Google Scholar
• Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. JACC Cardiovasc Interv. 2009;2(1):17–25.
   Web of Science ®Google Scholar
• Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116(Suppl 11):I200–I206.
   Web of Science ®Google Scholar
• Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012; 366(16):1467–1476.
   PubMed Web of Science ®Google Scholar
• Morrison DA, Seti G, Sacks J, et al; Investigators of the Department of Veterans Affairs Cooperative Study #385, Angina With Extremely Serious Operative Mortality Evaluation. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40(11):1951–1954.
   PubMed Web of Science ®Google Scholar
• Kamalesh M, Sharp TG, Tang C, et al; VA CARDS Investigators. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J Am Coll Cardiol. 2013;61(8):808–816.
   PubMed Web of Science ®Google Scholar
• Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDIA (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55(5):432–440.
   PubMed Web of Science ®Google Scholar
• Kappetein P, Head SJ, Morice MC, et al; SYNTAX Investigators. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43(5):1006–1013.
   PubMed Web of Science ®Google Scholar
• Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55(11):1067–1075.
   Web of Science ®Google Scholar
• Farkouh ME, Domanski M, Sleeper LA, et al; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375–2384.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kumar S, Fusaro M, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012;125(23):2873–2891.
   PubMed Web of Science ®Google Scholar
• Magnuson EA, Farkouh ME, Fuster V, et al; FREEDOM Trial Investigators. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Circulation. 2013;127(7):820–831.
   PubMed Web of Science ®Google Scholar
• Hlatky MA. Compelling evidence for coronary-bypass surgery in patients with diabetes. N Engl J Med. 2012;367(25):2437–2438.
   Web of Science ®Google Scholar
• Molardi A, Benassi F, Nicolini F, Maestri F, Gherli T. Coronary artery bypass grafting in diabetic patients: Should we still use the saphenous vein graft? A review of literature in the past 15 years. World J Cardiovasc Dis. 2013;3(4A):13–24.
   Google Scholar
• Taggart DP., Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg. 2006;82(6):1966–1975.
   PubMed Web of Science ®Google Scholar
• Schwartz L, Kip KE, Frye RL, Alderman EL, Schaff HV, Detre KM; Bypass Angioplasty Revascularization Investigation. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 2002;106(21):2652–2658.
   Web of Science ®Google Scholar
• Hoogwerf BJ, Waness A, Cressman M, et al. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes. 1999;48(6):1289–1294.
   Web of Science ®Google Scholar
• Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136(3):631–640.
   PubMed Web of Science ®Google Scholar
• Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008;86(5):1431–1437.
   PubMed Web of Science ®Google Scholar
• Leavitt BJ, Sheppard L, Maloney C, et al; Northern New England Cardiovascular Disease Study Group. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation. 2004;110(11 Suppl 1):1141–1144.
   Web of Science ®Google Scholar
• Hannan EL, Wu C, Bennett EV, et al. Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol. 2006;47(3):661–668.
   PubMed Web of Science ®Google Scholar
• Hannan EL, Farrell LS, Wechsler A, et al. The New York risk score for in-hospital and 30-day mortality for coronary artery bypass graft surgery. Ann Thorac Surg. 2013;95(1):46–52.
   Web of Science ®Google Scholar
• Wu C, Camacho FT, Wechsler AS, et al. Risk score for predicting long-term mortality after coronary artery bypass graft surgery. Circulation. 2012;125(20):2423–2430.
   PubMed Web of Science ®Google Scholar
• Hannan E, Wu C, Smith CR, et al. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation. 2007;116(10):1145–1152.
   Web of Science ®Google Scholar
• Zacharias A, Schwann T, Riordan C, Durham S, Shah A, Habib R. Late results of conventional versus all-arterial revascularization based on internal thoracic and radial artery grafting. Ann Thorac Surg. 2009;87(1):19–26. e2.
   Web of Science ®Google Scholar
• Chocron S, Baillot R, Rouleau JL, et al; IMAGINE Investigators. Impact of previous percutaneous transluminalcoronary angioplasty and/or stentingrevascularization on outcomes after surgical revascularization: insights from the imagine study. Eur Heart J. 2008;29(5):673–679.
   Google Scholar
• Thielmann M, Neuhäuser M, Stephan Knipp S, et al. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007;134(2):470–476.
   Web of Science ®Google Scholar
• Rao C, Stanbridge Rde L, Chikwe J, et al. Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study. Ann Thorac Surg. 2008;85(2):501–507.
   Web of Science ®Google Scholar
• Tonino PA, De Bruyne B, Pijls HJ et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. NEng J Med. 2009;360:213–224.
   PubMed Web of Science ®Google Scholar
• Botman CJ, Schonberger J, Koolen S, et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg. 2007;83(6):2093–2097.
   Web of Science ®Google Scholar
• Lazar H. Fractional flow-guided coronary artery bypass grafting: a word of caution. Circulation. 2013;128(13):1393–1395.
   Web of Science ®Google Scholar
• Tatoulis J, Buxton BF, Fuller JA, et al. Long-term patency of 1108 radial-coronary angiograms over 10 years. Ann Thorac Surg. 2009;88(1):23–29.
   Web of Science ®Google Scholar
• Dorman MJ, Kurlansky PA, Traad EA, Galbut DL, Zucker M, Ebra G. Bilateral internal mammary grafting enhances survival in diabetic patients: 30-year follow-up of propensity score-matched cohorts. Circulation. 2012;126(25):2935–2942.
   PubMed Web of Science ®Google Scholar
• Puskas JD, Sadiq A, Vassiliades TA, Kilgo PD, Lattouf LM. Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients. Ann Thorac Surg. 2012;94(3):710–715; discussion 715–716.
   Web of Science ®Google Scholar
• Acar C, Hebara VA, Portoghese M, et al. Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg. 1992;54(4):652–659; discussion 659–660.
   PubMed Web of Science ®Google Scholar
• Dimitrova KR, Hoffman DM, Geller CM, et al. Radial artery grafting in women improves 15-year survival. J Thorac Cardiovasc Surg. 2013;146(6):1467–1473.
   PubMed Web of Science ®Google Scholar
• Habib RH, Abou-Arraj NE, Schwann TA. Radial artery as a second arterial graft in the elderly and both sexes. Ann Cardiothorac Surg. 2013;2(4):453–457.
   Google Scholar
• Tranbaugh RF, Dimitrova KR, Friedmann P, et al. Coronary artery bypass grafting using the radial artery: clinical outcomes, patency and need for reintervention. Circulation. 2012;126(11 Suppl 1):S170–S175.
   Web of Science ®Google Scholar
• Tatoulis J, Buxton BF, Fuller JA. The radial artery in reoperative coronary bypass surgery. J Card Surg. 2004;19(4):296–302.
   Web of Science ®Google Scholar
• Khot UN, Friedman DT, Pettersson G, Smedira NG, Li J, Ellis SG. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation. 2004;109(17):2086–2091.
   PubMed Web of Science ®Google Scholar
• Ruttmann E, Fischler N, Sakic A, et al. Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study. Circulation. 2011;124(12):1321–1329.
   Web of Science ®Google Scholar
• Ruttmann E, Fischler N, Sakic A, et al. Response to letters regarding article, “Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study”. Circulation. 2012;125:e631.
   Web of Science ®Google Scholar
• Collins P, Webb CM, Chong CF, Moat NE; Radial Artery Versus Saphenous Vein Patency (RSVP) Trial Investigators. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation. 2008;117(22):2859–2864.
   PubMed Web of Science ®Google Scholar
• Possati G, Gaudino M, Prati F, et al. Long-term results of the radial artery used for myocardial revascularization. Circulation. 2003;108(11):1350–1354.
   Web of Science ®Google Scholar
• Hoffman D, Dimitrova KR, Lucido D, et al. The optimal arterial conduit for diabetic patients: a propensity analysis of the radial artery versus the right internal thoracic artery. Presented at: Society of Thoracic Surgeons 50th Annual Meeting; January 25–29, 2014; Orlando, FL.
   Google Scholar
• Navia D, Vrancic M, Piccinini F, et al. Is the second internal thoracic artery better than the radial artery in total arterial off-pump coronary artery bypass grafting? A propensity score-matched follow-up study. J Thorac Cardiovasc Surg. Epub April 6, 2013.
   Google Scholar
• Locker C, Schaff HV, Dearani JA, et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass surgery: analysis of 8622 patients with multivessel disease. Circulation. 2012;126(9):1023–1030.
   Web of Science ®Google Scholar
• Hoffman DM, Dimitrova KR, DeCastro H, et al. Improving long term outcomes for diabetic patients undergoing surgical revascularization by use of the radial artery conduit: a propensity matched study. J Cardiothorac Surg. 2013;8:27.
   Web of Science ®Google Scholar
• Schwann TA, Al-Shaar L, Engoren M, Habib RH. Late effects of radial artery vs saphenous vein grafting for multivessel coronary bypass surgery in diabetics: a propensity-matched analysis. Eur J Cardiothorac Surg. 2013;44(4):701–710.
   Web of Science ®Google Scholar
• Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Late results of conventional versus all-arterial revascularization based on internal thoracic and radial artery grafting. Ann Thorac Surg. 2009;87(1):19–26. e2.
   Web of Science ®Google Scholar
• Tavilla G, Kappetein AP, Braun J, Gopie J, Tjien AT, Dion RA. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries. Ann Thorac Surg. 2004;77(3):794–799; discussion 799.
   Web of Science ®Google Scholar
• Suma H, Tanabe H, Takahashi A, et al. Twenty years experience with the gastroepiploic artery graft for CABG. Circulation. 2007; 116(Suppl 11):I188–I191.
   Web of Science ®Google Scholar
• Glineur D, D’Hoore W, de Kerchove L, et al. Angiographic predictors of 3-year patency of bypass grafts implanted on the right coronary artery system: a prospective randomized comparison of gastroepiploic, saphenous vein, and right internal thoracic artery grafts. J Thorac Cardiovasc Surg. 2011;142(5):980–988.
   Web of Science ®Google Scholar
• Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(23):2610–2642.
   PubMed Web of Science ®Google Scholar
• Verma S, Farkouh ME, Yanagawa B, et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: A meta-analysis of randomized controlled trials. Lancet Diabetes Endocrinol. 2013;1(4):317–328.
   PubMed Web of Science ®Google Scholar
• Lazar HL, McDonnell M, Chipkin SR, et al; Society of Thoracic Surgeons Blood Glucose Guideline Task Force. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663–669.
   Web of Science ®Google Scholar
• Furnary AP, Gao GQ, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–1021.
   PubMed Web of Science ®Google Scholar
• Sokos GG, Bolukoglu H, German J, et al. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2007;100(5):824–829.
   PubMed Web of Science ®Google Scholar
• Straumann E, Kurz DJ, Muntwyler J, et al. Admission glucose concentrations independently predict early and later mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J. 2005;150(5):1000–1006.
   Web of Science ®Google Scholar
• Quinn DW, Pagano D, Bonser RS, et al ; Study Investigators. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg. 2006;131(1):34–42.
   Web of Science ®Google Scholar
• West NE, Ruygrok PN, Disco CM, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation. 2004;109(7):867–873.
   Web of Science ®Google Scholar
• Moreno PR, Murcia AM, Palacios IF, et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation. 2000;102(18):2180–2184.
   PubMed Web of Science ®Google Scholar
• Lupi A, Navarese EP, Lazzero M, et al. Drug-eluting stents vs bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. Circ J. 2011;75(2):280–289.
   Web of Science ®Google Scholar
• Kojima S, Sakamoto T, Ogawa H, et al; Multicenter Study for Aggressive Lipid-lowering Strategy by HMG-CoA Reductase Inhibitors Investigators. Standard-dose statin therapy provides incremental clinical benefits in normocholesterolemic diabetic patients. Circ J. 2010;74(4):779–785.
   Google Scholar
• Ajjan R, Storey RF, Grant PJ. Aspirin resistance and diabetes mellitus. Diabetologia. 2008;51(3):385–390.
   Web of Science ®Google Scholar
• Mehta SS, Silver RJ, Aaronson A, Abrahamson M, Goldfine AB. Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus. Am J Cardiol. 2006;97(4):567–570.
   Web of Science ®Google Scholar
• Hlatky MA, Solomon MD, Shilane D, Leong TK, Brindis R, Go AS. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol. 2013;61(3):295–301.
   Web of Science ®Google Scholar